SCHEMBL16744262

SCHEMBL16744262

CC(C(=O)C(C)(C)C)c1cccc(C(=O)c2ccccc2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.71
PTGS1 P23219 5/20 0.71
PTGS2 P35354 5/20 0.71
SMN1; SMN2 Q16637 3/20 0.71
ALDH1A1 P00352 3/20 0.71
LMNA P02545 3/20 0.71
CXCR1 P25024 2/20 0.71
CXCR2 P25025 2/20 0.71
CYP3A4 P08684 2/20 0.71
RECQL P46063 1/20 0.71
KDM4E B2RXH2 1/20 0.71
HPGD P15428 1/20 0.71
MAPK1 P28482 1/20 0.71
PMP22 Q01453 1/20 0.71
SLC22A6 Q4U2R8 1/20 0.71
HSD17B10 Q99714 1/20 0.71
CXCL8 P10145 1/20 0.71
THPO P40225 1/20 0.71
HIF1A Q16665 1/20 0.71
HTT P42858 3/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13143567 1.00 MAPT (0.71) MAPTPTGS1PTGS2SMN1; SMN2ALDH1A1
SCHEMBL17854675 0.85 PTGS2 (0.50) MAPTPTGS1PTGS2SMN1; SMN2ALDH1A1
R-Ketoprofen SCHEMBL29353694 0.83 PTGS1 (1.00) MAPTPTGS1PTGS2SMN1; SMN2ALDH1A1
Ketoprofen SCHEMBL16757741 0.83 PTGS1 (1.00) MAPTPTGS1PTGS2SMN1; SMN2ALDH1A1
R-Ketoprofen SCHEMBL195303 0.83 PTGS1 (1.00) MAPTPTGS1PTGS2SMN1; SMN2ALDH1A1
Dexketoprofen SCHEMBL29396875 0.83 PTGS1 (1.00) MAPTPTGS1PTGS2SMN1; SMN2ALDH1A1
Ketoprofen SCHEMBL679920 0.83 PTGS1 (1.00) MAPTPTGS1PTGS2SMN1; SMN2ALDH1A1
Ketoprofen SCHEMBL8754790 0.83 PTGS1 (1.00) MAPTPTGS1PTGS2SMN1; SMN2ALDH1A1
Ketoprofen SCHEMBL3843886 0.83 PTGS1 (1.00) MAPTPTGS1PTGS2SMN1; SMN2ALDH1A1
Ketoprofen SCHEMBL8577572 0.83 PTGS1 (1.00) MAPTPTGS1PTGS2SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150148306-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATION KANDULA MAHESH (IN) 2015-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150148306-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATION IAPP, TTR, GPR119 MAPT 265/4885PTGS1 1641/4885PTGS2 2226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.